Literature DB >> 20060420

Effective siRNAs inhibit the replication of novel influenza A (H1N1) virus.

Wu Zhiqiang1, Yang Yaowu, Yang Fan, Yang Jian, Hu Yongfeng, Zhao Lina, Wang Jianwei, Jin Qi.   

Abstract

In March and April 2009, an entirely novel influenza A (H1N1) virus (NIAV) emerged in Mexico and the USA. During the subsequent months, the virus rapidly spread all over the world by person-to-person transmission. In this report, RNA interference (RNAi) was used as an antiviral agent to inhibit NIAV replication in A549 cells. Ten small interfering RNAs (siRNAs) targeting extremely conserved regions among multiple NIAV genomes could effectively block the replication of NIAV strain A/Beijing/01/2009 (H1N1) in A549 cells. This study may be useful to confront the sudden emergence of NIAV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20060420     DOI: 10.1016/j.antiviral.2009.12.010

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  6 in total

1.  Broad-spectrum antiviral activity of RNA interference against four genotypes of Japanese encephalitis virus based on single microRNA polycistrons.

Authors:  Zhiqiang Wu; Ying Xue; Bei Wang; Jiang Du; Qi Jin
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

2.  A novel ribozyme-based prophylaxis inhibits influenza A virus replication and protects from severe disease.

Authors:  Julie Motard; Ronan Rouxel; Alexandra Paun; Veronika von Messling; Martin Bisaillon; Jean-Pierre Perreault
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

3.  High antiviral effect of TiO2·PL-DNA nanocomposites targeted to conservative regions of (-)RNA and (+)RNA of influenza A virus in cell culture.

Authors:  Asya S Levina; Marina N Repkova; Elena V Bessudnova; Ekaterina I Filippova; Natalia A Mazurkova; Valentina F Zarytova
Journal:  Beilstein J Nanotechnol       Date:  2016-08-10       Impact factor: 3.649

Review 4.  Antiviral RNAi: translating science towards therapeutic success.

Authors:  Priya S Shah; David V Schaffer
Journal:  Pharm Res       Date:  2011-08-09       Impact factor: 4.200

5.  The highly conserved 5' untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2'-modified siRNAs.

Authors:  Jun-Xia Deng; Xiao-Jing Nie; Ying-Feng Lei; Chao-Feng Ma; Dong-Liang Xu; Biao Li; Zhi-Kai Xu; Guo-Cheng Zhang
Journal:  J Biomed Sci       Date:  2012-08-13       Impact factor: 8.410

6.  RNA Secondary Structure Motifs of the Influenza A Virus as Targets for siRNA-Mediated RNA Interference.

Authors:  Julita Piasecka; Elzbieta Lenartowicz; Marta Soszynska-Jozwiak; Barbara Szutkowska; Ryszard Kierzek; Elzbieta Kierzek
Journal:  Mol Ther Nucleic Acids       Date:  2019-12-24       Impact factor: 8.886

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.